Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.41
HLTH's Cash to Debt is ranked higher than
56% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. HLTH: 0.41 )
Ranked among companies with meaningful Cash to Debt only.
HLTH' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 3.91 Max: No Debt
Current: 0.41
Equity to Asset 0.54
HLTH's Equity to Asset is ranked higher than
58% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. HLTH: 0.54 )
Ranked among companies with meaningful Equity to Asset only.
HLTH' s Equity to Asset Range Over the Past 10 Years
Min: -0.73  Med: 0.4 Max: 0.81
Current: 0.54
-0.73
0.81
Interest Coverage 5.28
HLTH's Interest Coverage is ranked lower than
62% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.64 vs. HLTH: 5.28 )
Ranked among companies with meaningful Interest Coverage only.
HLTH' s Interest Coverage Range Over the Past 10 Years
Min: 19.82  Med: N/A Max: No Debt
Current: 5.28
F-Score: 6
Z-Score: 2.11
M-Score: -1.63
WACC vs ROIC
6.74%
28.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 4.99
HLTH's Operating margin (%) is ranked lower than
63% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 7.23 vs. HLTH: 4.99 )
Ranked among companies with meaningful Operating margin (%) only.
HLTH' s Operating margin (%) Range Over the Past 10 Years
Min: -89.06  Med: 14.3 Max: 64.77
Current: 4.99
-89.06
64.77
Net-margin (%) 15.80
HLTH's Net-margin (%) is ranked higher than
86% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 4.83 vs. HLTH: 15.80 )
Ranked among companies with meaningful Net-margin (%) only.
HLTH' s Net-margin (%) Range Over the Past 10 Years
Min: -243.59  Med: -5.85 Max: 22.18
Current: 15.8
-243.59
22.18
ROE (%) 36.63
HLTH's ROE (%) is ranked higher than
95% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. HLTH: 36.63 )
Ranked among companies with meaningful ROE (%) only.
HLTH' s ROE (%) Range Over the Past 10 Years
Min: -169.77  Med: -11.14 Max: 63.67
Current: 36.63
-169.77
63.67
ROA (%) 19.55
HLTH's ROA (%) is ranked higher than
95% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 4.14 vs. HLTH: 19.55 )
Ranked among companies with meaningful ROA (%) only.
HLTH' s ROA (%) Range Over the Past 10 Years
Min: -114.84  Med: -8.75 Max: 30.76
Current: 19.55
-114.84
30.76
ROC (Joel Greenblatt) (%) 23.13
HLTH's ROC (Joel Greenblatt) (%) is ranked higher than
55% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 19.67 vs. HLTH: 23.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLTH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -442.4  Med: 82.69 Max: 266.36
Current: 23.13
-442.4
266.36
Revenue Growth (3Y)(%) 93.40
HLTH's Revenue Growth (3Y)(%) is ranked higher than
98% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. HLTH: 93.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLTH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -51.2  Med: -21.7 Max: 187.9
Current: 93.4
-51.2
187.9
EBITDA Growth (3Y)(%) 70.80
HLTH's EBITDA Growth (3Y)(%) is ranked higher than
95% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. HLTH: 70.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HLTH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -53.6  Med: 7.3 Max: 128.4
Current: 70.8
-53.6
128.4
EPS Growth (3Y)(%) 215.50
HLTH's EPS Growth (3Y)(%) is ranked higher than
99% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. HLTH: 215.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HLTH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -80.2  Med: 52.65 Max: 215.5
Current: 215.5
-80.2
215.5
GuruFocus has detected 4 Warning Signs with Nobilis Health Corp $HLTH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HLTH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HLTH Guru Trades in Q4 2015

Jim Simons 95,600 sh (New)
Chuck Royce 960,700 sh (+162.06%)
» More
Q1 2016

HLTH Guru Trades in Q1 2016

Jim Simons 157,500 sh (+64.75%)
Chuck Royce 1,235,700 sh (+28.62%)
» More
Q2 2016

HLTH Guru Trades in Q2 2016

Chuck Royce 1,590,800 sh (+28.74%)
Jim Simons Sold Out
» More
Q3 2016

HLTH Guru Trades in Q3 2016

Jim Simons 33,500 sh (New)
Chuck Royce 1,515,800 sh (-4.71%)
» More
» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8619
Compare:NYSE:ADPT, NAS:BIOS, NYSE:AAC, NYSE:CCM, NYSE:QHC, OTCPK:MIHI, OTCPK:CATS, OTCPK:AMEH, NAS:JYNT, OTCPK:FCHS, OTCPK:CCEL, OTCPK:BNKL, AMEX:AMS, OTCPK:CVHIF, OTCPK:CPAI, AMEX:SSY, AMEX:HH, OTCPK:PFHO, OTCPK:QNIIF, OTCPK:WNDM » details
Traded in other countries:NHC.Canada, NH1.Germany,
Nobilis Health Corp is a healthcare development and management company. It is engaged in development and management of ambulatory surgical centers providing medical care & healthcare delivery services.

Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.

Ratios

vs
industry
vs
history
P/E(ttm) 3.76
HLTH's P/E(ttm) is ranked higher than
95% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.17 vs. HLTH: 3.76 )
Ranked among companies with meaningful P/E(ttm) only.
HLTH' s P/E(ttm) Range Over the Past 10 Years
Min: 2.87  Med: 15.53 Max: 315.98
Current: 3.76
2.87
315.98
PE(NRI) 3.76
HLTH's PE(NRI) is ranked higher than
95% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.51 vs. HLTH: 3.76 )
Ranked among companies with meaningful PE(NRI) only.
HLTH' s PE(NRI) Range Over the Past 10 Years
Min: 2.87  Med: 15.57 Max: 328.62
Current: 3.76
2.87
328.62
Price/Owner Earnings (ttm) 5.20
HLTH's Price/Owner Earnings (ttm) is ranked higher than
92% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 26.85 vs. HLTH: 5.20 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HLTH' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 3.54  Med: 16.93 Max: 610
Current: 5.2
3.54
610
P/B 1.29
HLTH's P/B is ranked higher than
79% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. HLTH: 1.29 )
Ranked among companies with meaningful P/B only.
HLTH' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 2.31 Max: 13.43
Current: 1.29
0.26
13.43
P/S 0.60
HLTH's P/S is ranked higher than
81% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. HLTH: 0.60 )
Ranked among companies with meaningful P/S only.
HLTH' s P/S Range Over the Past 10 Years
Min: 0.17  Med: 0.76 Max: 63.18
Current: 0.6
0.17
63.18
PFCF 23.25
HLTH's PFCF is ranked higher than
50% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 23.25 vs. HLTH: 23.25 )
Ranked among companies with meaningful PFCF only.
HLTH' s PFCF Range Over the Past 10 Years
Min: 0.4  Med: 9.25 Max: 250
Current: 23.25
0.4
250
POCF 12.33
HLTH's POCF is ranked higher than
63% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.44 vs. HLTH: 12.33 )
Ranked among companies with meaningful POCF only.
HLTH' s POCF Range Over the Past 10 Years
Min: 0.39  Med: 8.31 Max: 136.42
Current: 12.33
0.39
136.42
EV-to-EBIT 10.56
HLTH's EV-to-EBIT is ranked higher than
90% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 20.40 vs. HLTH: 10.56 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -2803.9  Med: 4.25 Max: 144.3
Current: 10.56
-2803.9
144.3
EV-to-EBITDA 7.29
HLTH's EV-to-EBITDA is ranked higher than
89% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 14.49 vs. HLTH: 7.29 )
Ranked among companies with meaningful EV-to-EBITDA only.
HLTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.7  Med: 4.15 Max: 119
Current: 7.29
-37.7
119
Current Ratio 2.19
HLTH's Current Ratio is ranked higher than
79% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. HLTH: 2.19 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s Current Ratio Range Over the Past 10 Years
Min: 0.56  Med: 2.74 Max: 6.55
Current: 2.19
0.56
6.55
Quick Ratio 2.10
HLTH's Quick Ratio is ranked higher than
80% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.14 vs. HLTH: 2.10 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.53  Med: 2.49 Max: 6.08
Current: 2.1
0.53
6.08
Days Inventory 7.00
HLTH's Days Inventory is ranked higher than
78% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. HLTH: 7.00 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s Days Inventory Range Over the Past 10 Years
Min: 16.83  Med: 30.69 Max: 56.21
Current: 7
16.83
56.21
Days Sales Outstanding 113.36
HLTH's Days Sales Outstanding is ranked lower than
92% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. HLTH: 113.36 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.97  Med: 71.41 Max: 175.75
Current: 113.36
30.97
175.75
Days Payable 36.00
HLTH's Days Payable is ranked lower than
53% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 38.65 vs. HLTH: 36.00 )
Ranked among companies with meaningful Days Payable only.
HLTH' s Days Payable Range Over the Past 10 Years
Min: 34.18  Med: 53.33 Max: 155.21
Current: 36
34.18
155.21

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -26.90
HLTH's 3-Year Average Share Buyback Ratio is ranked lower than
90% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HLTH: -26.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HLTH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -37.4  Med: -25.1 Max: 27.4
Current: -26.9
-37.4
27.4

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 57.20
HLTH's Price/Net Current Asset Value is ranked lower than
93% of the 54 Companies
in the Global Medical Care industry.

( Industry Median: 8.73 vs. HLTH: 57.20 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
HLTH' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.82  Med: 36.67 Max: 212.25
Current: 57.2
3.82
212.25
Price/Tangible Book 2.50
HLTH's Price/Tangible Book is ranked higher than
67% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 3.58 vs. HLTH: 2.50 )
Ranked among companies with meaningful Price/Tangible Book only.
HLTH' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.59  Med: 5.46 Max: 155
Current: 2.5
1.59
155
Price/Projected FCF 1.21
HLTH's Price/Projected FCF is ranked higher than
70% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.72 vs. HLTH: 1.21 )
Ranked among companies with meaningful Price/Projected FCF only.
HLTH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.45 Max: 5.31
Current: 1.21
0.05
5.31
Price/Median PS Value 0.78
HLTH's Price/Median PS Value is ranked higher than
77% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 1.02 vs. HLTH: 0.78 )
Ranked among companies with meaningful Price/Median PS Value only.
HLTH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.3  Med: 1.03 Max: 68.33
Current: 0.78
0.3
68.33
Price/Graham Number 0.65
HLTH's Price/Graham Number is ranked higher than
93% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 2.41 vs. HLTH: 0.65 )
Ranked among companies with meaningful Price/Graham Number only.
HLTH' s Price/Graham Number Range Over the Past 10 Years
Min: 0.56  Med: 1.12 Max: 6.26
Current: 0.65
0.56
6.26
Earnings Yield (Greenblatt) (%) 9.50
HLTH's Earnings Yield (Greenblatt) (%) is ranked higher than
92% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. HLTH: 9.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HLTH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.7  Med: 19.9 Max: 118.4
Current: 9.5
0.7
118.4

More Statistics

Revenue (TTM) (Mil) $273.8
EPS (TTM) $ 0.55
Beta-0.85
Short Percentage of Float13.96%
52-Week Range $1.80 - 4.66
Shares Outstanding (Mil)76.88

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 286 334 336 318
EPS ($) 0.33 0.37 0.37 0.39
EPS w/o NRI ($) 0.33 0.37 0.37 0.39
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for HLTH

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
NOBILIS HEALTH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 13 2017
Nobilis to Acquire Texas Based Vascular Business Jan 09 2017
Nobilis to Acquire Texas Based Vascular Business Jan 09 2017
Nobilis Health Corp.: Gathering momentum, can it sustain its performance? Jan 04 2017
NOBILIS HEALTH CORP. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Dec 22 2016
Nobilis Health Corp. Announces Notification of TSX De-Listing Review Regarding Warrants Dec 20 2016
ETFs with exposure to Nobilis Health Corp. : December 19, 2016 Dec 19 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 16 2016
Do Hedge Funds Love Nobilis Health Corp (USA) (HLTH)? Dec 16 2016
Nobilis Health Corp. Announces Voluntary Delisting from the Toronto Stock Exchange Dec 15 2016
ETFs with exposure to Nobilis Health Corp. : December 8, 2016 Dec 08 2016
NOBILIS HEALTH CORP. Financials Nov 16 2016
NOBILIS HEALTH CORP. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets,... Nov 15 2016
Nobilis to Present at Craig-Hallum Alpha Select Conference Nov 14 2016
ETF’s with exposure to Nobilis Health Corp. : November 10, 2016 Nov 10 2016
Nobilis Health Corp. :HLTH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 Nov 08 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Financial Statements and Exhibits Nov 07 2016
NOBILIS HEALTH CORP. Files SEC form 10-Q, Quarterly Report Nov 07 2016
Nobilis Health Reports Third Quarter 2016 Financial Results Nov 07 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of... Nov 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)